What Are the Returns on Value Investing?

Introduction

You're sizing up what returns to expect from value investing, so here's the quick takeaway: value investing aims to buy good assets for less than they're worth so you earn a premium over time. In practice that means buying stocks with low price versus fundamentals - P/E, P/B, free cash flow - where the market is punishing price, not fundamentals. Returns matter because they set your holding period, risk tolerance, and position size: expect multi-year waits, volatile interim returns, and plan portfolio weight accordingly; historically the long-run value premium has been roughly 3-5% annual versus growth over multi-decade windows (this can be defintely lumpy). One-liner: Value works when prices revert to fundamentals, but timing can be long and lumpy.

Key Takeaways

• Value investing aims to buy assets trading below fundamentals (P/E, P/B, FCF) to earn a long-run premium as prices revert to fundamentals.
• Historical studies typically find a roughly 3-5% annual value premium versus growth, but magnitude varies by region, cap, sector, and sample period.
• Expect multi-year waits and volatile interim returns-set holding-period, risk tolerance, and position sizes accordingly.
• Measure performance with CAGR, rolling 5-10 year excess returns, alpha vs factor models, and risk metrics (Sharpe, max drawdown); account for fees, turnover, and taxes.
• Mitigate risks via strategy design and testing: use quality filters, diversify (30-100 names), control position size, rebalance, and run robust backtests before scaling.

What Are the Returns on Value Investing?

You're sizing expectations for a value strategy; quick takeaway: value has historically earned a modest, persistent premium but the size and timing vary a lot, so set horizons and tests up front. One-liner: academic and industry studies show a persistent value premium, but its magnitude varies by sample and period.

Historical evidence and one-line takeaway

One-liner: long-term datasets (academic and industry) repeatedly show value beating growth over many decades, though not every decade. The canonical Fama-French literature and mutual-fund/asset-manager studies find a positive spread between cheap and expensive stocks when you measure price relative to fundamentals (price-to-book, price/earnings, price/free-cash-flow).

Steps for you: pull at least two independent sources (Kenneth French data library or Fama-French factors, and a commercial index series such as Russell or MSCI) and compute cumulative returns back to 1926-1930 where possible. Best practices: use total-return series (dividends reinvested), remove survivor bias, and compare value definitions (P/B vs P/E vs cash-flow) to test robustness.

• Check rolling 10- and 20-year spreads
• Compare global and US series separately
• Document data vintage and reconstitution rules

What to watch: sample start date shifts the result; pre-war data is thin, and post-1980 structural market changes matter. If you see a long negative drawdown, that may be a timing issue, not proof the premium is dead - but it could be a regime shift, so test further.

Typical long-run magnitudes and recent history

One-liner: long-run studies (Fama-French, Ibbotson, others) typically report a value premium in the range of about 3-5% annualized versus growth across the 20th and early 21st centuries. That's the rough ballpark investors should use for planning.

Concrete example and quick math: if growth returns 8.0% CAGR and value returns 11.5% CAGR, the premium is 3.5 percentage points. Over 30 years that compounds - $1 grows to $10.06 at 11.5% and to $10.06? wait - sorry: at 11.5% $1 becomes about $22.2; at 8.0% it becomes about $10.1 - so the gap widens materially over decades. What this hides: short-term volatility is large; a single decade of underperformance is common.

Recent patterns to test using fiscal 2025 data: the 2010s and early-2020s featured multi-year growth rallies that compressed the premium; value then recovered in cycles around 2020-2024. Best practice: measure both calendar- and fiscal-year returns, and show rolling 5-year and 10-year CAGRs to see whether the premium has re-emerged or remains muted.

• Report both annualized excess return and hit rate
• Show max drawdown for value vs growth over test window
• Adjust recent years for sector rotations (tech vs energy, financials)

What the averages hide and actionable considerations

One-liner: the headline premium masks wide variation by region, market-cap, and sector - so slice the data before you decide size and exposure. Regional and cap nuances can flip the sign and size of the premium.

Practical steps: segment your analysis by region (US, Europe, EM), by cap (large vs small), and by sector. Run the following checks with fiscal-year 2025 data included: rolling 5-year excess returns, dispersion across the portfolio, and sector weight contribution to excess returns. That tells you whether observed premium is broad-based or driven by a few industries.

• Test small-cap vs large-cap value separately
• Decompose excess returns by sector contribution
• Run attribution to see if one or two stocks explain most of the premium
• Stress-test for secular change (e.g., platform economics in tech)

Best practices and guardrails: if value outperformance is concentrated in cyclicals (energy, materials), expect higher volatility and deeper drawdowns in downturns. If small-caps drive the premium, add liquidity buffers and higher transaction-cost assumptions. What this estimate hides: structural sector shifts (like growth of intangible assets) can permanently compress classic value signals - so add quality screens (profitability, cash flow) when needed.

How returns are measured (practical metrics)

Pick metrics that match your goal

You're sizing expectations for a value strategy, so pick metrics that answer the question you actually care about: do you want to grow wealth, demonstrate manager skill, or compare risk-adjusted outcomes?

One-liner: pick metrics that match your goal-absolute return for wealth, alpha for manager skill, risk-adjusted for comparability.

Practical steps

• Decide primary objective: wealth accumulation, benchmark outperformance, or risk control.
• Map metric to objective: use CAGR for wealth, alpha for skill, Sharpe/Sortino for risk-adjustment.
• Always measure net of fees, trading costs, and realistic taxes before judging performance.
• Use consistent horizons (5y or 10y) and the same rebalancing/tax assumptions across tests.
• Document assumptions up front: return frequency (daily/monthly), business-day calendar, and data source cutoffs (include fiscal‑year 2025 endpoints).

Best practice: lock the measurement objective first; everything else follows.

Key measures and how to compute them

You're building a reporting suite-here are the exact formulas, how to annualize, and the gotchas to avoid.

One-liner: use CAGR for realized growth, alpha for skill, and Sharpe/Sortino and max drawdown for plain risk context.

Core measures and how to compute

• CAGR (compound annual growth rate): CAGR = (Ending value / Starting value)^(1 / years) - 1. Example: $100 → $160 in 5 years: CAGR = (160/100)^(1/5) - 1 ≈ 10%.
• Cumulative excess return: compute total return of portfolio minus total return of benchmark over the same period (both geometric). Use the same compounding basis.
• Alpha: run time-series regression of portfolio excess returns versus factor returns. Single-factor: Rp - Rf = alpha + beta(Rm - Rf) + ε. Multi-factor (recommended): include market, size, value (Fama-French), profitability, investment. Alpha is the intercept - the manager's risk‑adjusted outperformance.
• Sharpe ratio: (Rp - Rf) / σ(Rp - Rf). Annualize mean and volatility from daily/monthly returns: mean_daily252, vol_dailysqrt(252).
• Sortino ratio (downside risk): (Rp - Rf) / downside deviation. Prefer when upside volatility is fine.
• Max drawdown: peak-to-trough percentage decline. Compute on total-return series (not price only) and report duration and recovery date.

Measurement tips

• Use total-return series (dividends included); otherwise CAGR understates income-heavy strategies.
• Annualize consistently: for daily data use 252 trading days; for monthly use 12 months.
• Subtract realized fees and trading costs before computing alpha or Sharpe - gross metrics mislead.
• Control for look-ahead and survivorship bias in historical datasets; use live, investable index data where possible.

Quick caveat: alpha from short sample windows is noisy; show t-stats and p-values, not just the intercept.

Benchmarks, factors, and quick math for rolling windows

If you want to know whether value is working now, compare to consistent benchmarks and run rolling windows to see persistence.

One-liner: use Russell 1000 Value, MSCI World Value, and the Fama-French value factor for consistent comparisons.

Benchmarks and factor choices

• Use Russell 1000 Value for US large-cap value context.
• Use MSCI World Value for global value exposure.
• Use the Fama-French value factor (HML or the modern value factor in a 5-factor model) for factor regressions and attribution.

How to compute rolling 5- and 10-year CAGRs and excess returns - step by step

• Gather total-return series with fiscal‑year 2025 as the latest point; align dates to month-ends or quarter-ends.
• For each window end date t, set start = t - 5 years (or 10 years).
• Compute CAGR_portfolio(t) = (V_t / V_start)^(1/years) - 1.
• Compute CAGR_benchmark(t) the same way over identical dates.
• Compute excess(t) = CAGR_portfolio(t) - CAGR_benchmark(t).
• Aggregate across windows: report mean excess, median, standard deviation, and percent of windows with positive excess.

Quick math example (illustrative)

Portfolio: $100 → $161 over 5 years → CAGR = (161/100)^(1/5) - 1 ≈ 10%. Benchmark: $100 → $140 → CAGR ≈ 7%. Excess = 3% annualized.

Adjust for costs: assume round-trip trading + slippage = 0.5% annually and management fee = 0.75%; net excess falls to ~1.75% in this toy example.

Best practices for rolling tests

• Report net-of-costs numbers and show sensitivity (fee ±25 bps, slippage ±50 bps).
• Show calendar-year and peak-to-trough behaviors to reveal lumpy underperformance periods.
• Break out results by market cap and sector - value premium often differs across small vs large and by sector mix.
• Run statistical tests for persistence (bootstrap or paired t-tests across windows) and report confidence levels.

Next step and owner: You: run a 5-year rolling-return test versus Russell 1000 Value using fiscal 2025 data by Friday; Portfolio: report net annualized excess return and max drawdown.

Drivers that produce the premium

You want to know why value investing delivers a return edge and what actually creates that premium so you can size positions, set holding periods, and avoid common traps. The quick takeaway: the premium comes from mispricing, risk compensation, and mean reversion of fundamentals.

Behavioral drivers: mispricing from investor psychology

One-liner: investors overreact to short-term news and favor growth, which pushes prices away from fundamentals.

Why it matters: when investors chase momentum or panic-sell, cheap stocks can trade below intrinsic value for months or years. That creates opportunities for disciplined buyers who ignore headlines.

Practical steps you can use right away:

• Screen for sentiment extremes: select names with large recent underperformance versus sector peers over 6-24 months.
• Require a margin of safety: buy when market price is below your conservative intrinsic value by at least 20-40%.
• Document trigger events: list the specific news (earnings miss, legal issue, temporary demand shock) you expect to resolve within 6-24 months.
• Hold rules: be prepared to wait 3-7 years for mean reversion in fundamentals; sell only when fundamentals no longer target recovery.

Here's the quick math: if a mispriced stock is 30% below fair value and you expect a 4% annualized recovery premium, typical payback over 3-5 years is plausible - but timing is uncertain, so size positions accordingly.

Economic drivers: risk compensation and mean reversion in earnings

One-liner: cheap assets often carry higher distress or illiquidity risk, so expected returns include compensation for that risk plus natural mean reversion in earnings and cash flow.

How to measure and act:

• Quantify risk premium: compare expected free cash flow yield to safe rates; a stock with FCF yield 6% vs Treasury yield 2% implies a 4% premium cushion.
• Adjust for distress: raise required return when leverage, covenant risk, or cyclicality is high - e.g., add 3-6 percentage points to your hurdle rate for highly leveraged names.
• Model mean reversion: build earnings scenarios where below-trend margins recover halfway to historical mean over 3-7 years.
• Stress test liquidity: assume wider bid-ask spreads and 10-50% higher transaction costs for low-liquidity names when sizing positions.

What this hides: some cheap names are cheap for structural reasons (secular decline), not cyclical ones. Distinguish temporary dislocations from permanent impairment before assuming mean reversion.

Manager drivers: how active choices realize alpha

One-liner: disciplined margin-of-safety buying, methodical rebalancing, and opportunistic corporate actions convert a gross value premium into net outperformance.

Concrete practices that add value:

• Define clear entry rules: require valuation screens (e.g., P/B below sector median, FCF yield above 6-8%) plus a qualitative thesis.
• Rebalance systematically: trim winners and add to losers on a quarterly cadence to harvest mean reversion and control drift.
• Use corporate actions: monitor buybacks, asset sales, and restructurings - these can accelerate recovery; target names where management commits > 3-5% of market cap to buybacks.
• Control implementation costs: model turnover and trading costs up front; if fees and taxes are ~1.5%-2.0% per year, your gross premium of 3-5% annualized can fall substantially.
• Govern risk: cap position sizes (e.g., 3%-5% of portfolio per position), diversify across 30-100 names, and set review triggers at predefined valuation or operational milestones.

What to expect: if the academic value premium is in the range of 3-5% annualized, and you incur 1.5%-2% of implementation costs, your net edge shrinks - so process discipline and low costs are essential to keep the premium alive. Also, defintely track outcomes with rolling 5- and 10-year excess returns to see if your active choices actually add alpha.

Key risks and return drags

You're sizing a value allocation and want to understand what can erode the premium over time - the long droughts, the stocks that never recover, and the real costs of running the strategy. Here's the quick takeaway: value can underperform for long stretches, and implementation costs plus structural shifts can shave meaningful percentage points off gross returns.

Value can underperform for long stretches; implementation costs and structural shifts reduce net returns

One-liner: value can lag growth for years, so set your horizon, sizing, and patience up front.

How long. Expect underperformance windows of multiple years; plan for 5-12 year drawdown phases in worst-case regimes. What to do: treat those periods as part of the bet, not a bug - size positions smaller, keep cash or diversifiers ready, and measure on rolling 5- and 10-year returns.

Quick math example: assume a historical gross value premium of 4% annualized. If fees and costs total 2.5% and taxes add 0.5%, your net premium can fall to about 1.0%. What this estimate hides: higher turnover, larger spreads in small-cap names, or a concentrated sector bet can double the cost hit.

• Set target holding period: minimum 5 years
• Limit a single-position hit to 3%-5% of portfolio market value
• Track rolling net excess return vs Russell 1000 Value

Value traps: low-price stocks that decline further due to secular decline or fraud

One-liner: buying cheap isn't the same as buying recoverable - identify structural decline and governance risk before you add size.

How to spot traps: check 3-year revenue CAGR, 3-year free cash flow trend, return on invested capital (ROIC), and leverage. Red flags include persistent negative FCF, revenue shrinkage, debt/EBITDA > 4x, repeated auditor changes, or outsized insider selling. A single fraud or permanent business failure can wipe out >90% of equity value, so these checks aren't optional.

Practical steps and thresholds to avoid traps:

• Screen out names with negative FCF for 3 consecutive years
• Exclude companies with ROIC 5% and falling revenue
• Require net cash or debt/EBITDA ≤4x for deep-value picks
• Use governance flags: auditor changes, related-party deals, and insider sales > 5% of free float

Portfolio rule: cap initial position size at 1%-3% of portfolio for high-risk deep-value names and run a 6-12 month due-diligence watch before scaling. If fundamental recovery evidence doesn't appear in your review window, cut exposure - this is defintely one place to be surgical.

Implementation frictions: turnover, trading costs, taxes, and fees can shave several percentage points per year

One-liner: gross alpha is one thing - net alpha after real-world frictions is what you actually earn.

Common drags and practical numbers (assumptions you should model): turnover 50%-100% annually; round-trip trading costs (spread + market impact + commissions) typically add 0.5%-1.0% for institutional-sized trades, higher for small-cap names; active management fees range from 0.5%-1.5%; taxable accounts can incur 0.3%-1.0% in annual tax drag depending on turnover and realized gains.

Mitigations and best practices:

• Target turnover ≤50% for taxable strategies; use longer holding windows
• Use benchmark-aware crossing and algorithmic trading to cut market impact
• Prefer ETFs or index-based value wrappers for retail to reduce fees and tax inefficiency
• Implement tax-loss harvesting and match rebalances to long-term holding thresholds
• Assume net drag in modelling: fees + trading + taxes = 1.0%-2.5% annually

Operational rules: rebalance quarterly, set a maximum implementation cost budget (for example, 1.0% expected annual drag), and log realized turnover and tax impact monthly. Action for you: run a net-of-costs scenario modelling the strategy using fiscal-year 2025 trading-cost and fee assumptions and report the projected annualized excess return and max drawdown by Friday; Portfolio: own the rebalancing rules and execution plan.

How to test and implement a value strategy

Start small, measure rigorously, and scale what proves persistent

You're ready to test value investing but don't want to blow capital or chase luck - here's a tight way to start.

One-liner: build small experiments, measure with robust metrics, and scale what proves persistent.

Steps to start an experiment

• Define hypothesis - e.g., bottom 30% by P/B in Russell 1000 outperforms over 5 years after costs.
• Set capital - start with a paper or small live sleeve, like $100,000 notional.
• Pick universe and lookback - use fiscal-year 2025 trailing fundamentals where available (TTM or FY2025 filings) and freeze data at rebalancing dates.
• Fix trading rules - position cap 3% of portfolio, rebalance quarterly, use VWAP or 15‑min benchmarks for execution.
• Record decisions - keep a trade log with signals, valuation metrics, and reason for each buy/sell.

What to measure daily/weekly

• Rolling CAGRs (5y and 10y), cumulative excess return vs Russell 1000 Value.
• Alpha from a 3‑factor or 5‑factor regression (Fama-French).
• Drawdowns and recovery time; turnover and estimated slippage.

Quick operational rules

• Run the experiment for at least 36 months live or simulated to see lumpy outcomes.
• If net annualized excess 0.5%-1.0% after costs stays persistent, scale gradually.
• If onboarding/settling takes >14 days, stop and fix process - it raises churn risk.

Strategy variants and a tight backtest checklist

If you're choosing an approach, pick from tested variants and harden your backtests to avoid false positives.

Common variants

• Deep value - extreme screens (lowest 10%-20% by P/E or P/B), higher turnover, higher expected slippage.
• Quality‑value - value screens plus profitability rules (ROIC > 8%-10%, positive free cash flow) to reduce value traps.
• Value + momentum - buy cheap stocks that also show 6-12 month relative strength to time mean reversion.

Backtest checklist (use FY2025 data to capture recent regime shifts)

• Out‑of‑sample test - reserve the most recent 30% of your timeframe for validation.
• Avoid look‑ahead bias - use only data available at the rebalancing date (use filing dates from SEC EDGAR).
• Include realistic transaction costs - assume 0.25%-0.50% per trade for large-cap US, 0.75%-1.50% for small-cap; add market impact if >1% position size.
• Model slippage - use time‑of‑day VWAP slippage estimates or historical fill data.
• Tax and fees - test gross and net of a management fee (e.g., 1.0%) + performance fee (if relevant); model long‑term vs short‑term tax effects.
• Stress tests - run scenarios for sector concentration, rising rates, and a 30% market drawdown using FY2025 balance‑sheet snapshots.
• Documentation - archive code, datasets, and a README stating data source and refresh date (e.g., FactSet/Compustat snapshot as of 30‑Sep‑2025).

What this finds vs what it hides

• Variant choice changes turnover, sector bets, and expected excess - deep value often beats gross but loses more to costs.
• FY2025 inputs matter - earnings quality and buyback activity in 2024-2025 shifted many value signals; test with those specific numbers.

Portfolio rules and a practical rolling 5‑year excess return example

You need clear position limits, rebalance cadence, and failure triggers so behavior stays disciplined in bad stretches.

Core portfolio rules

• Hold 30-100 names to balance concentration and execution cost.
• Cap any position at 3%-5% of portfolio at cost.
• Rebalance quarterly and only trade into target bands (e.g., +/- 10% band) to limit turnover.
• Stop‑loss / review triggers - review if a position falls 30% from purchase or if ROIC drops below your quality threshold.
• Risk limits - sector exposure capped at 25% to avoid cyclical concentration (common in value).

Practical example: rolling 5‑year excess return vs Russell 1000 Value - how to run it

Step 1: Gather inputs

• Daily/monthly total return series for your strategy and Russell 1000 Value, covering at least 10 years that include FY2025.
• Strategy NAV series built from rebalanced portfolio returns net of modeled trading costs and fees using FY2025 cost assumptions.

Step 2: Compute rolling 5‑year CAGRs

• For each month t compute CAGR over prior 60 months: CAGR = (End NAV / Start NAV)^(12/60) - 1.
• Compute same for benchmark.
• Rolling excess = strategy 5‑yr CAGR - benchmark 5‑yr CAGR.

Illustrative math (replace with your FY2025-sourced returns)

• Assume strategy 5‑yr CAGR = 12.0% and Russell 1000 Value 5‑yr CAGR = 8.0% → rolling excess = 4.0 percentage points annually.
• Adjust for costs: trading costs 0.5%, fees 1.0% → net excess = 4.0% - 1.5% = 2.5%.
• Compute max drawdown over same rolling window and record recovery time.

What to report

• Net annualized excess return (after estimated trading costs and fees) - report as percentage points.
• Median rolling excess and % of rolling windows where excess > 0.
• Max drawdown and time to recovery for each 5‑yr window.

What this estimate hides

• Execution quality - live fills can be worse than modeled slippage.
• Changing regimes - FY2025 may show higher buybacks or different sector cycles; update inputs quarterly.

Next step and owner

You: run a 5‑year rolling‑return test versus Russell 1000 Value using fiscal‑year 2025 data by Friday; Portfolio: report net annualized excess return and max drawdown.

What Are the Returns on Value Investing?

Value tends to offer a modest, persistent premium if you accept patience, discipline, and implementation holes

You're deciding if value deserves a place in your portfolio; the short answer: historically value has delivered a modest premium but it's neither steady nor fast. One clean line: value often adds about 3-5% annualized versus growth over long periods, but those gains can take years to appear and come in lumpy chunks.

Here's the quick math you should keep front of mind: if a value sleeve compounds at 4% above a growth benchmark, after 10 years a $1,000 stake becomes roughly $1,480 extra versus the benchmark. What this estimate hides: multi-year droughts, regional differences, and implementation drag (fees, taxes, turnover).

Actionable practice: set expectations up front-plan to hold value exposures for at least 5-10 years, and measure performance in rolling windows rather than year-to-year. If you can't wait that long, scale back allocation or use a smaller, experimental sleeve.

Investment decision: pick a clear variant, set windows, and define acceptable underperformance

One-liner: choose a single, testable version of value and stick to regular measurement rules. For example, pick between deep value (cheap by P/B or EV/EBITDA), quality-value (cheap but profitable), or value+momentum hybrids.

Concrete steps:

• Define universe: e.g., Russell 1000 Value total-return index.
• Pick screens: P/E < median OR P/B < median; for quality add ROIC > 8%.
• Positioning: target 30-100 names; cap position at 3% of portfolio.
• Holding & rebalance: rebalance quarterly; review flags monthly.
• Underperformance rule: accept 3 years of trailing underperformance before a strategy review, unless drawdown exceeds threshold.

Risk controls: set a maximum permitted drawdown for the sleeve at 25%; trigger a forensic review if exceeded. Practical example: a quality-value sleeve with 50 names, quarterly rebalance, and a 3% cap limits single-stock blowups and trading churn.

What to watch: sector concentration (energy, financials) can bias returns; add cap or sector limits to avoid accidental bets.

Next step and owner: run the tests and report specific metrics using fiscal 2025 data

One-liner: run a focused experiment this week and get hard numbers back-net annualized excess return, volatility, and max drawdown.

Immediate task for you: run a rolling 5‑year excess-return test versus the Russell 1000 Value using fiscal 2025 data and submit results by Friday, Dec 5, 2025. Deliverables:

• Net annualized excess return (after assumed fees)
• Max drawdown over the test window
• Sharpe ratio and turnover estimate
• Tax and transaction cost assumptions used

How to run it (practical checklist):

• Source total-return prices for your universe and Russell 1000 Value through fiscal 2025.
• Compute rolling 5-year CAGRs for strategy and benchmark.
• Subtract benchmark CAGR to get gross excess return, then subtract fees (e.g., management 0.75-1.50%) and trading costs (estimate 0.25-1.00% annualized depending on turnover) to get net.
• Report max drawdown and the longest consecutive underperformance period.

Owner: You run the test; Portfolio team compiles a one-page memo with the figures above and a recommended action (scale, pause, or refine) by Dec 5, 2025. If onboarding or data access delays push the timeline past that date, flag me immediately-delays beyond 7 days materially change decision timing.